0000000000532603

AUTHOR

Sabini Mg

showing 6 related works from this author

Nuovo Centro PET –Ciclotrone Azienda Ospedaliera Cannizzaro Catania: problemi e strategie progettuali

2005

researchProduct

Radiation Protection Evaluations about PET Cyclotrons

2007

researchProduct

Commissioning e Verifiche Dosimetriche della nuova unità Gamma Knife dell’A.O. Cannizzaro di Catania

2005

researchProduct

Verifiche dosimetriche delle distribuzioni di dose previste dal Treatment Planning System (TPS) Leksell Gamma Plan (LGP)

2005

researchProduct

prove su sistemi di monitoraggio continuo di campi magnetici statici "TALETE TECNORAD"

2006

researchProduct

Evaluation of erlotinib treatment response in non-small cell lung cancer using metabolic and anatomic criteria

2016

BACKGROUND: In this paper the clinical value of PET for early prediction of tumor response to erlotinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen is evaluated. The aim was to compare the early metabolic treatment response using European Organization for Research and Treatment of Cancer (EORTC) 1999 recommendations and PET Response Criteria in Solid Tumors (PERCIST), and the standard treatment response using Response Evaluation Criteria in Solid Tumors (RECIST). METHODS: Twenty patients with stage IV NSCLCwere enrolled prospectively. PET/CT studies were performed before, then 48 hours, and 45 days after…

AdultMaleLung NeoplasmsTime FactorsAntineoplastic AgentsKaplan-Meier EstimateAdult; Aged; Antineoplastic Agents; Carcinoma Non-Small-Cell Lung; Disease-Free Survival; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Time Factors; Treatment OutcomeResponse evaluation criteria in solid tumorDisease-Free SurvivalErlotinib Hydrochloridenon–small cell lung cancerPositron Emission Tomography Computed TomographyHumansProspective StudiesNon-Small-Cell LungAgedCarcinomaMiddle AgedCarcinoma non-small-cell lungEORTCTreatment OutcomeRECISTResponse evaluation criteria in solid tumorsFemalePositron-emission tomographyPERCISTDiagnosi18F-FDG PET
researchProduct